S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
The Bio-Tech Stock That Needs Your Attention! (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
The Bio-Tech Stock That Needs Your Attention! (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Asian shares fall over China worries, Seoul trading closed for a holiday
The Bio-Tech Stock That Needs Your Attention! (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
How You Can Reverse Engineer Michael Burry's Latest Buy
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
The Bio-Tech Stock That Needs Your Attention! (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
The Bio-Tech Stock That Needs Your Attention! (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Asian shares fall over China worries, Seoul trading closed for a holiday
The Bio-Tech Stock That Needs Your Attention! (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
How You Can Reverse Engineer Michael Burry's Latest Buy
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
The Bio-Tech Stock That Needs Your Attention! (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
The Bio-Tech Stock That Needs Your Attention! (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Asian shares fall over China worries, Seoul trading closed for a holiday
The Bio-Tech Stock That Needs Your Attention! (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
How You Can Reverse Engineer Michael Burry's Latest Buy
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
The Bio-Tech Stock That Needs Your Attention! (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
The Bio-Tech Stock That Needs Your Attention! (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Asian shares fall over China worries, Seoul trading closed for a holiday
The Bio-Tech Stock That Needs Your Attention! (Ad)
This Little Known Automaker May Save Your Life and Your Portfolio
How You Can Reverse Engineer Michael Burry's Latest Buy
NASDAQ:ICUI

ICU Medical (ICUI) Stock Forecast, Price & News

$117.00
+1.73 (+1.50%)
(As of 09/27/2023 ET)
Compare
Today's Range
$115.17
$118.26
50-Day Range
$115.27
$178.18
52-Week Range
$114.04
$212.43
Volume
191,270 shs
Average Volume
190,040 shs
Market Capitalization
$2.82 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$216.00

ICU Medical MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
84.6% Upside
$216.00 Price Target
Short Interest
Healthy
5.43% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.47
Upright™ Environmental Score
News Sentiment
1.01mentions of ICU Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$6.28 M Sold Last Quarter
Proj. Earnings Growth
11.39%
From $5.18 to $5.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.42 out of 5 stars

Medical Sector

240th out of 976 stocks

Surgical & Medical Instruments Industry

32nd out of 98 stocks


ICUI stock logo

About ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICUI Price History

ICUI Stock News Headlines

A Bio-Tech Stock That Has Been Growing Like Crazy!
Recent News for This One Bio-Tech Has Us All Getting Excited. Sign Up today And Learn More
ICU Medical: Continued Disappointments
A Bio-Tech Stock That Has Been Growing Like Crazy!
Recent News for This One Bio-Tech Has Us All Getting Excited. Sign Up today And Learn More
ICU Medical Q2 Earnings Summary
ICU Medical (ICUI) Beats Q2 Earnings Estimates
The Medical Care That Helps No One
Q1 2023 ICU Medical Inc Earnings Call
See More Headlines
Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICUI Company Calendar

Last Earnings
8/07/2023
Today
9/28/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
14,500
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$216.00
High Stock Price Forecast
$216.00
Low Stock Price Forecast
$216.00
Forecasted Upside/Downside
+84.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-74,290,000.00
Pretax Margin
-3.44%

Debt

Sales & Book Value

Annual Sales
$2.29 billion
Cash Flow
$16.60 per share
Book Value
$87.15 per share

Miscellaneous

Free Float
22,293,000
Market Cap
$2.82 billion
Optionable
Optionable
Beta
0.64

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Vivek  JainMr. Vivek Jain (Age 51)
    CEO & Chairman
    Comp: $1.16M
  • Mr. Brian Michael Bonnell (Age 49)
    CFO & Treasurer
    Comp: $618.92k
  • Mr. Christian B. Voigtlander (Age 54)
    Chief Operating Officer
    Comp: $651.42k
  • Ms. Virginia Ruth SanzoneMs. Virginia Ruth Sanzone (Age 48)
    Corp. VP, Gen. Counsel, Sec. & Compliance Officer
    Comp: $552.73k
  • Clay Fradd
    Corp. VP of HR













ICUI Stock - Frequently Asked Questions

Should I buy or sell ICU Medical stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ICUI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ICUI, but not buy additional shares or sell existing shares.
View ICUI analyst ratings
or view top-rated stocks.

What is ICU Medical's stock price forecast for 2023?

1 Wall Street research analysts have issued 1 year target prices for ICU Medical's stock. Their ICUI share price forecasts range from $216.00 to $216.00. On average, they anticipate the company's stock price to reach $216.00 in the next year. This suggests a possible upside of 84.6% from the stock's current price.
View analysts price targets for ICUI
or view top-rated stocks among Wall Street analysts.

How have ICUI shares performed in 2023?

ICU Medical's stock was trading at $157.48 at the beginning of 2023. Since then, ICUI stock has decreased by 25.7% and is now trading at $117.00.
View the best growth stocks for 2023 here
.

Are investors shorting ICU Medical?

ICU Medical saw a decrease in short interest in September. As of September 15th, there was short interest totaling 1,100,000 shares, a decrease of 5.2% from the August 31st total of 1,160,000 shares. Based on an average trading volume of 199,700 shares, the short-interest ratio is currently 5.5 days. Approximately 5.4% of the shares of the company are sold short.
View ICU Medical's Short Interest
.

When is ICU Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our ICUI earnings forecast
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) posted its earnings results on Monday, August, 7th. The medical instruments supplier reported $1.58 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.43. The medical instruments supplier earned $549.31 million during the quarter, compared to analysts' expectations of $562.90 million. ICU Medical had a negative net margin of 2.11% and a positive trailing twelve-month return on equity of 6.93%.

What ETFs hold ICU Medical's stock?

ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), Fidelity Disruptive Medicine ETF (FMED) and Principal Healthcare Innovators ETF (BTEC) and

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical issued an update on its FY23 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of $6.00-6.85 for the period, compared to the consensus EPS estimate of $6.70.

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and Company (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.12%), JPMorgan Chase & Co. (3.00%), Victory Capital Management Inc. (2.66%), State Street Corp (2.52%), Segall Bryant & Hamill LLC (1.54%) and Allspring Global Investments Holdings LLC (1.34%). Insiders that own company stock include Christian B Voigtlander, Daniel Woolson, Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends
.

How do I buy shares of ICU Medical?

Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $117.00.

How much money does ICU Medical make?

ICU Medical (NASDAQ:ICUI) has a market capitalization of $2.82 billion and generates $2.29 billion in revenue each year. The medical instruments supplier earns $-74,290,000.00 in net income (profit) each year or ($2.02) on an earnings per share basis.

How many employees does ICU Medical have?

The company employs 14,500 workers across the globe.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The official website for the company is www.icumed.com. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at ir@icumed.com, or via fax at 949-366-8368.

This page (NASDAQ:ICUI) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -